European equities traded in the US as American depositary receipts were tracking higher Thursday morning, rising 0.71% to 1,554.06 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and pharmaceutical company Novo Nordisk (NVO), which climbed 8.3% and 6.6%, respectively. They were followed by 3D printer company Materialise (MTLS) and biopharmaceutical company Cellectis (CLLS), which advanced 4.5% and 4.1%, respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies (DBVT) and telecommunications operator Telefonica (TEF), which fell 1.4% and 1.2%, respectively. They were followed by financial services company ING Group (ING) and petroleum refiner Equinor (EQNR), which were off 0.6% and 0.4%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Akari Therapeutics (AKTX), which rose 14% and 9%, respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company NuCana (NCNA), which were up 5.9% and 3.7%, respectively.

The decliners from the UK and Ireland were led by pharmaceutical company AstraZeneca (AZN) and tobacco company British American Tobacco (BTI), which dropped 1.9% and 1.8%, respectively. They were followed by telecommunications operator Vodafone Group (VOD) and mining company BHP Group (BHP), which were down 1.7% and 1.4%, respectively.